Literature DB >> 23158636

Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib.

Pedram Gerami, Jennifer Sorrell, Mary Martini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23158636     DOI： 10.1016/j.jaad.2012.05.031

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  Cutaneous toxicities of new treatments for melanoma.

Authors:  A Boada; C Carrera; S Segura; H Collgros; P Pasquali; D Bodet; S Puig; J Malvehy
Journal:  Clin Transl Oncol       Date:  2018-05-24       Impact factor: 3.405

2.  Appearance of New Vemurafenib-associated Melanocytic Nevi on Normal-appearing Skin: Case Series and a Review of Changing or New Pigmented Lesions in Patients with Metastatic Malignant Melanoma After Initiating Treatment with Vemurafenib.

Authors:  Philip R Cohen; Agop Y Bedikian; Kevin B Kim
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

3.  Melanoma patients under vemurafenib: prospective follow-up of melanocytic lesions by digital dermoscopy.

Authors:  Marie Perier-Muzet; Luc Thomas; Nicolas Poulalhon; Sébastien Debarbieux; Pierre-Paul Bringuier; Gerard Duru; Lauriane Depaepe; Brigitte Balme; Stephane Dalle
Journal:  J Invest Dermatol       Date:  2013-11-07       Impact factor: 8.551

4.  Dermoscopic assessment of skin toxicities in patients with melanoma during treatment with vemurafenib.

Authors:  Marcin Rajczykowski; Grazyna Kaminska-Winciorek; Elzbieta Nowara; Marzenna Samborska-Plewicka; Sebastian Giebel
Journal:  Postepy Dermatol Alergol       Date:  2018-02-20       Impact factor: 1.837
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.